Health
Mutant gene-targeted immunotherapy approach developed – Medical Xpress
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer Immunotherapy…
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new antibodies against genetically altered proteins to target cancers.
The researchers targeted their immunotherapy approach to alterations in the common cancer-related p53 tumor suppressor gene, the RAS tumor-promoting oncogene or T-cell receptor genes. They also tested the therapy…
-
General20 hours agoBeijing deal will expedite rare earth exports, says US
-
General19 hours agoMarkets rally on China-US trade hope, Iran peace deal
-
Noosa News22 hours agoCCTV shows the teenager accused of killing Greg Josephson after his death in Clayfield
-
General22 hours agoThe kids aren’t alright | The Spectator Australia